Clinical Trial Update: Pilot Study of CC 486 (Oral Azacitidine) Plus BSC as Maintenance After sc Azacitidine in Elderly HR-IPSS-R MDS Patients [Phase 2]

View source ↗

Summary

Pilot Phase 2 study evaluating CC-486 (oral azacitidine) plus best supportive care as maintenance after subcutaneous azacitidine in elderly patients with high-r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• CC-486 (oral azacitidine) (azacitidine)

Snippet

Sponsor: University of Florence | Conditions: MDS, CMML | Phase 2 | Status: ACTIVE_NOT_RECRUITING